Trial Profile

Observational study on the effects of IL-6 inhibitor therapy on adipokines in patients with rheumatoid arthritis

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tocilizumab (Primary)
Indications Rheumatoid arthritis
Focus Adverse reactions; Pharmacodynamics

Most Recent Events

11 May 2016 Status changed from completed to active, no longer recruiting.
02 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
23 Apr 2015 Planned End Date changed from 1 Sep 2015 to 1 Aug 2015 as reported by ISRCTN: Current Controlled Trials.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com